The Limit of Limits: India’s Hurdles in Regulating Antimicrobial Pollution

In this CIDRAP-ASP report, we analyze the events surrounding the proposal and eventual removal of the limits, describing the issue of antibiotic pollution in India within the larger context of pharmaceutical demand and outsourcing of manufacture from high-income countries (HICs), the role of India as a competitive and necessary source of pharmaceuticals during the COVID-19 pandemic, criticisms raised about the antibiotic waste limits from diverse viewpoints and interests, and potential next steps for ensuring that the issue of environmental pollution remains in the foreground of all discussion about antibiotic innovation and manufacture.